home / stock / nmtr / nmtr quote
Last: | $0.0722 |
---|---|
Change Percent: | 12.88% |
Open: | $0.1103 |
Close: | $0.0722 |
High: | $0.1127 |
Low: | $0.0715 |
Volume: | 5,278,566 |
Last Trade Date Time: | 07/25/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0722 | $0.1103 | $0.0722 | $0.1127 | $0.0715 | 5,278,566 | 07-25-2023 |
$0.1266 | $0.1341 | $0.1266 | $0.1358 | $0.121 | 2,806,145 | 07-24-2023 |
$0.1507 | $0.149 | $0.1507 | $0.1594 | $0.135 | 2,694,147 | 07-21-2023 |
$0.153 | $0.174 | $0.153 | $0.1779 | $0.141 | 3,425,019 | 07-20-2023 |
$0.1706 | $0.19 | $0.1706 | $0.19 | $0.165 | 4,360,994 | 07-19-2023 |
$0.195 | $0.1941 | $0.195 | $0.225 | $0.1806 | 7,912,142 | 07-18-2023 |
$0.6221 | $0.68 | $0.6221 | $0.6979 | $0.6 | 1,731,407 | 07-17-2023 |
$0.675 | $0.677 | $0.675 | $0.696599 | $0.6701 | 55,032 | 07-14-2023 |
$0.675 | $0.68 | $0.675 | $0.6905 | $0.66 | 37,283 | 07-13-2023 |
$0.6701 | $0.6835 | $0.6701 | $0.688 | $0.6605 | 26,843 | 07-12-2023 |
$0.675 | $0.662 | $0.675 | $0.69 | $0.662 | 18,462 | 07-11-2023 |
$0.662 | $0.66 | $0.662 | $0.6899 | $0.65 | 27,246 | 07-10-2023 |
$0.66 | $0.6767 | $0.66 | $0.69 | $0.6556 | 46,002 | 07-07-2023 |
$0.67 | $0.7 | $0.67 | $0.7 | $0.65 | 22,783 | 07-06-2023 |
$0.67 | $0.67 | $0.67 | $0.7138 | $0.67 | 60,564 | 07-05-2023 |
$0.67 | $0.68 | $0.672 | $0.68 | $0.65 | 23,537 | 07-04-2023 |
$0.67 | $0.68 | $0.67 | $0.68 | $0.65 | 23,537 | 07-03-2023 |
$0.672 | $0.67 | $0.672 | $0.6842 | $0.6601 | 29,785 | 06-30-2023 |
$0.6782 | $0.66 | $0.6782 | $0.6845 | $0.66 | 47,954 | 06-29-2023 |
$0.652 | $0.65 | $0.652 | $0.6728 | $0.6408 | 23,070 | 06-28-2023 |
News, Short Squeeze, Breakout and More Instantly...
9 Meters Biopharma Inc. Company Name:
NMTR Stock Symbol:
NASDAQ Market:
RALEIGH, NC / ACCESSWIRE / May 30, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced that the Board of Directors has accepted the resignation of John Temperato as President ...
RALEIGH, NC / ACCESSWIRE / May 15, 2023 / 9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2...
RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of a written response from the U.S. Food and Drug Administration (FDA) on the r...